Production of more Aβ can in turn affect the up-regulation of BACE1-AS, leading to the formation of more plaques in the brain of AD patients, and finally aggravating the disease development (Faghihi et al., 2008[34]) (Figure 2(Fig. 2)). This evidence concerns the gene BACE1 and Alzheimer disease.